European Dividend Aristocrat Novo Nordisk reports 9.0% revenue growth in Q4
European Dividend aristocrat and Danish pharmaceutical company Novo Nordisk AS (NOVO-B.CO) reported on Wednesday a revenue growth of 9.0% and 4.8% earnings-per-share growth in Q4. Net profit in Q4 rose to 8.72 billion DKK ($1.29 billion) from DKK8.5 billion a year earlier. Sales in Q4 rose to DKK32.42 billion against analysts’ expectations of DKK31.95 billion.…